Mesoblast Draws US$50 Million from Five-Year Facility Backed by Director George
Mesoblast Limited drew US$50 million from a five-year credit facility provided by existing shareholder and director Dr. Gregory George. The non-dilutive drawdown allows the company to retire short-term maturing debt while maintaining cash on hand.
Mesoblast Limited drew US$50 million from a five-year credit facility provided by existing shareholder and director Dr. Gregory George, the company disclosed June 24. The drawdown is the second tranche from the facility; a first tranche of up to US$50 million was available to be drawn until June 30, 2026 [2]. Mesoblast held US$122 million cash at March 30, 2026 [1].
The facility allows Mesoblast to retire short-term maturing debt with non-dilutive capital at a lower cost, according to the release. Dr. George is both a director and an existing shareholder; the company did not disclose the interest rate, repayment schedule, or covenants attached to the five-year term.
Continue reading
2 more paragraphs for subscribers.
Free readers get a daily preview and the weekly long-form. Premium unlocks every brief in full, AM & PM editions, alerts, and the archive.